Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
8,275.00
26.5 (0.32%)
BSENSE

Aug 10

BSE+NSE Vol: 4.56 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,275.00",
    "chg": 26.5,
    "chgp": "0.32%",
    "dir": 1,
    "prev_price": "8,248.50",
    "mcapval": "220,431.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "4.56 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4000096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_4000096.png",
        "date": "2026-05-20 08:01:52",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a range of technical indicators. This change has prompted an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Golden Cross Confirmed: Do Divis Laboratories Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3999496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_goldencross_3999496.png",
        "date": "2026-05-19 18:00:16",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Divis Laboratories Ltd, signalling a golden cross on 19 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      }
    ],
    "total": 15,
    "sid": "509760",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-Aug-2026",
      "details": "Submission of transcript of Earnings Conference Call held on August 01 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Aug-2026",
      "details": "Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "01-Aug-2026",
      "details": "As per enclosed letter.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

06-Aug-2026 | Source : BSE

Submission of transcript of Earnings Conference Call held on August 01 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

03-Aug-2026 | Source : BSE

Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30 2026

Announcement under Regulation 30 (LODR)-Change in Management

01-Aug-2026 | Source : BSE

As per enclosed letter.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Divis Laboratories Ltd has declared 1500% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07

stock-summary
BONUS

Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15

stock-summary
RIGHTS

No Rights history available